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Abstract
Increase in cases of various cancers has encouraged the researchers to discover novel, more effective drugs from plant sources.
This study is a review of medicinal plants in Iran with already investigated anticancer effects on various cell lines. Thirty-six
medicinal plants alongside their products with anticancer effects as well as the most important plant compounds responsible
for the plants’ anticancer effect were introduced. Phenolic and alkaloid compounds were demonstrated to have anticancer effects
on various cancers in most studies. The plants and their active compounds exerted anticancer effects by removing free radicals
and antioxidant effects, cell cycle arrest, induction of apoptosis, and inhibition of angiogenesis. The investigated plants in Iran
contain the compounds that are able to contribute effectively to fighting cancer cells. Therefore, the extract and active com-
pounds of the medicinal plants introduced in this review article could open a way to conduct clinical trials on cancer and greatly
help researchers and pharmacists develop new anticancer drugs.
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Introduction
Cancer is a main reason for mortality involving more than one-
third of the global population in some way. Cancer is the cause
of more than 20% of the whole mortality worldwide.1 Accord-
ing to the report of the International Agency for Research on
Cancer2 of the World Health Organization published in 2014,
the global incidence of cancer has been approximately 14 mil-
lion new cases and is projected to register 19.3 million in 2025.
According to this report, lung cancer was the most prevalent
cancer (13%) in 2012 followed by breast cancer (11.9%), colon
cancer (9.7%), and prostate cancer (7.9%). In Iran, the mean
rate of cancer incidence has been 7.134 per 100 000 population,
85 000 individuals are estimated to acquire cancer and nearly
55 000 individuals die due to cancer per year.2,3
Meanwhile, there are a variety of therapeutic approaches to
treat cancer, including surgery, chemotherapy, radiation therapy,
hormone therapy, and immunotherapy. Despite being highly
efficient, surgery is not always practical under any circum-
stances. For radiotherapy, systemic radiotherapy is variously
conducted, including external radiation therapy, brachiotherapy,
and internal radiation therapy in view of the source and site of
tumor and the type of cells with several side effects, alongside
therapeutic effect, for the patient such as poisoning as the
most significant one leading to variation in skin health as
alopecia and destruction of epithelial cells (scaling) and
epithelial moisture (dermis revealing and skin secretion of
serous fluid) and potentially mouth ulcers and complications,
bone marrow suppression, and development of anemia, leuko-
penia, and thrombocytopenia.4 Chemotherapy drugs, includ-
ing antimetabolites (such as methotrexate), passive material
of DNA (such as cisplatin and doxorubicin), antitubulin
agents (such as taxis), and hormones that are most frequently
used cause unwanted effects, including hair loss, bone mar-
row suppression, drug resistance, gastric ulcer, neurological
dysfunction, and cardiac toxicity.5-7
In view of the above complications of the therapies currently
considered for cancer, high costs of conventional therapies, and
growing incidence of cancer in both developed and developing
countries, it seems necessary to develop more novel approaches
with higher efficiency so that the disease intensity could be
declined. In this regard, there is considerable scientific and
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commercial interest in developing new anticancer agents from nat-
ural sources and the research aimed to develop new anticancer
drugs has been turned into a significant research area.8 In fact,
naturally derived combinations have been under pharmacists’
focus to synthesize new drugs and treat diseases due to availability,
less frequent side effects and drug interactions, and cheapness.9,10
Plants produce a wide spectrum of chemical compounds
with apparently no direct contribution to their growth and
development, namely secondary metabolites. Terpenes,
nitrogen-containing, and phenolic compounds are 3 main
classes of these compounds with various biological properties
in plants that are used for a wide variety of diseases including
cancers,11,12 neurological disorders,13 chronic inflammation
and lesions, particularly due to diabetes,14,15 atherosclero-
sis,16,17 cardiovascular diseases,18,19 and wounds.20 In addition,
these natural products have been used alongside radiotherapy.
This article is a review of Iran’s medicinal plants that have
been already examined for anticancer effects, and also seeks to
offer their main compounds and mechanisms of anticancer
activities. This review article could open a way to develop new
anticancer drugs for prevention and treatment of cancers.
Materials and Methods
In this systematic review, to collect data, different combinations of
keywords medicinal plants, anticancer, Iran, cytotoxicity, cell line,
and phytochemical compounds and their Persian equivalents were
entered into databases consisting of Magiran, SID, and Iran Medex,
as well as, international databases of Web of Knowledge, PubMed,
and Scopus. The articles only in English and Persian languages pub-
lished between 1976 and March, 2015 were only searched. Then, the
articles on application of Iran’s medicinal plants for prevention and
treatment of cancers were selected, and those demonstrating antican-
cer effects of these plants and/or their compounds were reported.
Results
From the findings, 36 medicinal plants in Iran with studies con-
ducted on their anticancer effects were reported (Table 1).
Despite the fact that lung cancer has been the most prevalent
cancer in 2014, little research has been conducted on the effects
of medicinal plants on this cancer. Most studies have addressed
breast cancer (Table 2). In most conducted studies, no clear
mechanism of the plant effect has been offered. However, some
compounds of the plants have been reported to be possibly
responsible for anticancer effects. In addition, in some of the
studies some compounds were extracted from the plants and the
effect of these compounds on various cell lines were studied.
Phenolic and alkaloid compounds were demonstrated to have
anticancer effects on various cancers in most studies.
Discussion
The available therapeutic approaches to treat cancers are
mostly accompanied with undesirable side effects (gastroin-
testinal disorders, kidney damage, etc). The present study indi-
cated that the studied medicinal plants in Iran contain the
compounds engaging specifically in fighting cancer cells and
inhibiting growth and destruction of tumor cells only by affect-
ing cancer cells.
These compounds mainly include alkaloids and phenolic
and monoterpene compounds. Vinblastine, vincristine, curcu-
min, myrtucommulone, taxol, boswellic acids, and umbellipre-
nin, quercetin, catechin, cucurbitacin, kaempferol, thymol,
carvacrol, 1,8-cineole, a-pinene, myrecene, b-sitosterol were
some compounds with reported anticancer effects in most
works. Alkaloids are nitrogen-containing compounds with
plant origin, which often have a complex structure, high mole-
cular weight, and show physiological activity in humans. Alka-
loids cause cell cycle arrest in metaphase stage by preventing
the formation of microtubules and hence could prevent
cancer.172
Cancers and most difficult-to-cure diseases are associated
with high level of oxidative stress.173-175 Oxidative stress is a
phenomenon which may cause damage to various physiologi-
cal and biochemical processes. Overproduction of such free
radicals may also cause oxidative damage to biomolecules such
as DNA, lipids, and proteins.176-178 This process eventually
may lead to many chronic diseases, including cancer, athero-
sclerosis, diabetes, aging, and other degenerative diseases in
humans.179-181 Most of medicinal plants with anticancer prop-
erty have antioxidant activity due to phenolic compounds.
Therefore, these plants may, at least in part, exert their antican-
cer effects by counteracting free radicals. Antioxidant property
of phenolic compounds (including flavonols and flavonoids) is
due to the presence of hydroxyl groups.182,183 Actually, medic-
inal plants with antioxidant activity play a crucial role in
scavenging free radicals. They also are able to reduce the toxi-
city of toxic agents which induce oxidative stress.184-188 If this
is true, other plants with antioxidant property are likely to have
anticancer activity, which should be further investigated.
On the other hand, the ability to induce apoptosis is an
important marker for cytotoxic antitumor agents. Studies have
shown that cytotoxic effect of alkaloids and phenols against
different tumors is mediated through apoptosis.
Phenolic compounds exhibit anticancer effects through
affecting cell proliferation processes (eg, through the G2/M
cell cycle arrest and inhibition of topoisomerase II), apoptosis,
angiogenesis, and the impact on the routes of phosphoinositide
3-kinase (PI3-K) and protein kinase B (Akt). Studies have
demonstrated that inhibition of PI3-K activity inhibits phos-
phorylation of Akt and mammalian target of rapamycin
(mTOR), which leads to reduced activity of nuclear factor-
kB (NF-kB). Through this mechanism, transcription and synth-
esis of the cell cycle-driving proteins are inhibited and thus
the growth of cancer cells is reduced and the cell death
increases.189-192 For example, quercetin, a phenolic compound
in plants, prevents the activation of the transcription factor
NF-kB through inhibiting Akt and Ikka-a phosphorylation and
hence the anticancer activity is exerted.193 Curcumin, as a
major pigment in turmeric, induces apoptosis in transformed
rodent and human cells in inhibition of the culture of formation
of cyclooxygenase metabolite.69-72
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Table 1. Anticancer Effects of Various Iranian Medicinal Plants.
Scientific Name Part(s) Used Important Compounds Mechanisms References
Ferula assa-foetida Shoot, resin Coumarin compounds (especially
sesquicoumarins), sulfur-containing
compounds, andb-sitosterol andoleic acid
Inhibition of mutagenesis, DNA destruction
and cancer cells proliferation; increase of
proteolytic enzymes activity
21–24
Thymus vulgaris Shoot Thymol and carvacrol Cell cycle arrest 25–27
Thymbra spicata Shoot Thymol and carvacrol Inhibition of DNA destruction 28–30
Taverniera spartea Shoot Isoflavonoid compounds and saponins Induction of necrosis and apoptosis 31, 32
Peganum harmala Seed Alkaloids Induction of apoptosis (by caspase activation
and increase of proteolytic enzymes activity)
33–35
Viola tricolor Shoot Flavonoids (especially rutin and quercetin) Cell cycle arrest 36–38
Achillea wilhelmsii Shoot Phenolic compounds (especially flavonoids
and monoterpens such as 1,8-cineole and
a-pinene)
Induction of apoptosis 39–43
Mentha pulegium Shoot Pulegone, menthone, piperitone, limonene,
isomenthone, octen-3-ol
Induction of apoptosis 44–46
Ammi visnaga Shoot Visnadine, cimifugin, khellol, b-sitosterol,
kaempferol, quercetin
Cell cycle arrest 47–50
Camellia sinensis Leaf Epicatechin, epigallocatechin,
epigallocatechin gallate, epigallocatechin-
3-gallate
Inhibition of cancer cells proliferation (by
inhibit of 5-a reductase enzyme activity)
20, 51–55
Avicennia marina Leaf Flavonoids (especially naphthoquinone
compounds such as 3-
chlorodeoxylapachol)
Antioxidant effects; induction of apoptosis 56–58
Silybum marianum Seed Flavonoids (especially silymarin) Antioxidant effects; cell cycle arrest 59, 60
Artemisia absinthium L Root, shoot Artemisinin, quercetin, isorhamnetin,
limonene, myrecene, linalool, a-pinene,
b-pinene, artesunate
Inhibition of cancer cells proliferation
(decrease in response to nuclear receptors);
inhibition of angiogenesis and cell migration;
induction of apoptosis
61–64
Curcuma longa Rhizome Curcumin Inhibition of cancer cells proliferation
(by adjusting gene expression); inhibition
of angiogenesis; induction of apoptosis
65–72
Crocus sativus L Stigma Phenolic compounds (especially quercetin) Inhibition of cancer cells proliferation (inhibits
DNA synthesis)
73–76
Zingiber officinale Rhizome Flavonoids (especially kaempferol, catechin,
fisetin, and quercetin)
Induction of apoptosis 66, 77, 78
Olea europae Leaf, fruit Oleic acid, pinoresinol, oleuropein, acidic
triterpenes, oleanolic acid, maslinic acid
Inhibition of cancer cells proliferation
(inhibition of HER2 gene expression);
inhibition of angiogenesis; induction of
apoptosis
52, 79–81
Taxus baccata L Leaf Taxol Cell cycle arrest 82–84
Nigella sativa Seed Thymoquinone, dinitroquinone Cell cycle arrest; induction of apoptosis 85–90
Allium sativum L Fruit Allicin, ajoene Cell cycle arrest; induction of apoptosis 91–101
Lepidium sativum Shoot Vitamins (A, B, C and E), isothiocyanate, a-
linolenic acid, glucosinolates
Antioxidant effects; cell cycle arrest 102–104
Trigonella foenum-
graceum L
Shoot Flavonoids and alkaloids (such as gingerol,
cedrene, zingerone, vanillin, and eugenol)
Antioxidant effects; induction of apoptosis 105–108
Glycyrrhiza glabra Root Glycyrrhizin Inhibition of cancer cells proliferation (bcl-2
phosphorylation); morphological changes in
cancer cells and induction of apoptosis
109–112
Physalis alkekengi Fruit Physalins Induction of apoptosis 113–116
Lagenaria siceraria
Standl
Shoot, fruit Vitamins (B group and C), saponins,
cucurbitacin
Cell cycle arrest 117–121
Ferula gummosa Shoot Sesquiterpenes and coumarins Cell cycle arrest; induction of apoptosis 122–130
Boswellia serrata Resin Boswellic acid Inhibition of cancer cells proliferation
(distribution in the biosynthesis of nucleic
acids and proteins); decrease of cells viability
(increase of reactive oxygen species
production); induction of apoptosis (by
activation of caspases)
131–133
(continued)
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Table 2. Effect of Iranian Medicinal Plants on Different Cancers.
Target Organ Study Design Scientific Name Reference(s)
Lung Clinical trial Astragalus cystosus 146
Cell line: A549 Lagenaria siceraria Standl 117
Ferula gummosa (Umbelliprenin) 122
Rosa damascena 141
Curcuma longa 68
Cell line: SK-Mes-1 Thymbra spicata 28
Cell line: QU-DB Curcuma longa 67
Breast Mouse Silybum marianum 60
Trigonella foenum-graceum L 106
Cell line: BT-20 Avicennia marina (3-chlorodeoxylapachol) 58
Cell line: MDA-MB231 Avicennia marina 57
Zingiber officinale 78
Cell line: BT474 Olea europae 52
Taverniera spartea 32
Cell line: T47D Astrodaucus orientalis 169
Camellia sinensis 54
Curcuma longa 67
Ammi visnaga 48
Cell line: MDA-MB468 Taxus baccata L 83, 84
Cell line: MCF-7 Polygonum aviculare 167
Lagenaria siceraria Standl 119
Crocus sativus L 75
Zingiber officinale 77
Allium sativum L (diallyl disulfide) 95, 98
Vinca rosea (Alkaloids) 156
Glycyrrhiza glabra (glycyrrhizin) 112
Rosa damascena 141
Lepidium sativum 104
Ammi majus 139
Citrullus colocynthis (Cucurbitacin) 164
Taverniera spartea 32
Myrtus communis 149–151
Ferula gummosa 123
Cell line: 4T1 Glycyrrhiza glabra 110
Silybum marianum 60
(continued)
Table 1. (continued)
Scientific Name Part(s) Used Important Compounds Mechanisms References
Urtica dioica L Leaf Phenolic compounds Antioxidant effects; cell cycle arrest 134–138
Ammi majus Shoot, seed Coumarin compounds (especially
psoralens)
Cell cycle arrest; induction of apoptosis 139, 140
Rosa damascena Petal Phenolic compounds (such as gallic acid,
catechin, and epicatechin)
Antioxidant effects; DNA protection 141–144
Astragalus cystosus Shoot Lectins, flavonoids and terpenoids Cell cycle arrest; induction of apoptosis 145–148
Myrtus communis Leaf Polyphenols, myrtucommulone, semi-
myrtucommulone, 1,8-cineole, a-pinene,
myrtenyl acetate, limonene, linalool, a-
terpinolene
Antioxidant effects, induction of apoptosis
(DNA fragmentation and activation
caspases)
149–155
Vinca rosea Shoot Vincristine, vindoline, vinflunine, vinblastin,
catharantin
Antioxidant effects; inhibition of cancer cells
proliferation (effect on microtubules)
156–159
Citrullus colocynthis Fruit Cucurbitacin, quercetin, b-sitosterol Cell cycle arrest; induction of apoptosis 160–164
Polygonum aviculare Shoot Tannins, saponins, flavonoids and alkaloids Antioxidant effects; cell cycle arrest; induction
of apoptosis
165–168
Astroudaucus orientalis Root, shoot a-pinene, a-thujene, a-copaene, fenchyl-
acetate, myrecene, sabinene
Cell cycle arrest; induction of apoptosis 169–171
146 Journal of Evidence-Based Complementary & Alternative Medicine 21(2)
Conclusion
The investigated medicinal plants in this article could be a key
to identifying the compounds with anti-cancer effects; there-
fore, if their compounds are examined, they might help to
develop new, more efficient drugs, in addition to contributing
to identifying the main mechanisms involved in cancer.
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Table 2. (continued)
Target Organ Study Design Scientific Name Reference(s)
Prostate Clinical trial; Mouse; Cell line: LNCaP, hPCPs Urtica dioica 134–136
Mouse Thymus vulgaris 25
Cell line: DU-145 Taverniera spartea 32
Camellia sinensis 54
Cell line: PC-3 Ferula szowitsiana (Umbelliprenin) 126
Allium sativum L (diallyl disulfide) 96
Taverniera spartea 32
Cell line: PC-3M Curcuma longa 66
Zingiber officinale 66
Cervix Cell line: HeLa Ammi majus 139
Rosa damascena 142
Polygonum aviculare 165, 166
Physalis alkekengi 113, 116
Astragalus cystosus 145
Taxus baccata L 84
Peganum harmala 32, 33
Viola tricolor 36
Boswellia serrata 129
Curcuma longa (Curcumin) 70
Cell line: PA1 Ferula szowitsiana (Umbelliprenin) 126
Head Clinical trial Thymus vulgaris 26
Colon Cell line: RKO, SW480, HCT116 Olea europae (pinoresinol) 79
Cell line: HT-29, SW480, HCT116 Crocus sativus L 74
Cell line: HCT-116 Nigella sativa (Thymoquinone) 88
Cell line: HT-29 Artemisia absinthium L 62
Achillea wilhelmsii 39
Allium sativum L 93
Cell line: DLD-1 Ferula szowitsiana (Umbelliprenin) 126
Larynx Cell line: KB Avicennia marina (3-chlorodeoxylapachol) 58
Cell line: Hep-2 Citrullus colocynthis 160
Curcuma longa 65
Allium sativum L 94
Liver Cell line: HepG2 Astragalus cystosus (saponines and flavonoids) 147, 148
Ferula assa-foetida 21
Crocus sativus L 73, 76
Citrullus colocynthis (Cucurbitacin) 163
Skin Cell line: A431 Vinca rosea 156
Cell line: SK-MEL-28 Ferula gummosa 122
Blood cells Cell line: K562 Mentha pulegium 44
Artemisia absinthium L (Artesunate) 64
Lepidium sativum 103
Taxus baccata L 84
Cell line: Jurkat T-CLL, Raji B-CLL Ferula szowitsiana (Umbelliprenin) 125
Kidney Cell line: ACHN Nigella sativa 86
Bladder Cell line: ECV-304 Lepidium sativum 102
Stomach Cell line: AGS Ferula gummosa 124
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